Alexander Stevenson
Gründer bei 4D PHARMA PLC
Vermögen: 73 092 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Alexander Stevenson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
| Public Company | Pharmaceuticals: Major | 14 | |
| Public Company | Medical Specialties | 12 | |
Aquarius Equity Partners Ltd.
 Aquarius Equity Partners Ltd. Investment ManagersFinance Aquarius Equity Partners Ltd is an independent private equity firm founded in the year 2002 by Alan John Aubrey and Duncan Joseph Peyton headquarters in the UK.
5
| Private Company | Investment Managers | 5 |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Alexander Stevenson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Oxford | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree | |
| IP GROUP PLC | Miscellaneous Commercial Services | Founder Chief Executive Officer Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| University of Birmingham | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Corporate Officer/Principal | |
| University of Leeds | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| HVIVO PLC | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
| DEEPMATTER GROUP PLC | Packaged Software | Director/Board Member Chairman Chairman | |
| NANOCO GROUP PLC | Semiconductors | Director/Board Member Director/Board Member Director of Finance/CFO | |
Nanoco Technologies Ltd.
 Nanoco Technologies Ltd. SemiconductorsElectronic Technology Nanoco Technologies Ltd. researches and develops metal-free quantum dots and other nanomaterials. The company is headquartered in Manchester, the United Kingdom. | Semiconductors | Director/Board Member Director/Board Member Director/Board Member | |
Pharminox Ltd
 Pharminox Ltd Medical/Nursing ServicesHealth Services Pharminox Ltd develops treatments for cancer therapy. The private company is based in Abingdon, UK. The British company was founded by Neil L. Brown. | Medical/Nursing Services | Director/Board Member Chairman Director/Board Member | |
Modern Biosciences Ltd.
 Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The private company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman Chairman Founder | |
GT Biologics Ltd.
 GT Biologics Ltd. Pharmaceuticals: MajorHealth Technology GT Biologics Ltd. manufactures and distributes pharmaceutical products. It develops and commercializes an oral-based probiotic product for the treatment of mild to moderate Crohn's disease and ulcerative colitis and a novel family of protein, peptide therapeutics for the treatment of moderate to severe inflammatory bowel diseases. The company was founded by Denise Kelly in 2008 and is headquartered in Leeds, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Cambridge | College/University | Graduate Degree Doctorate Degree | |
ORA Capital Partners Ltd.
 ORA Capital Partners Ltd. Miscellaneous Commercial ServicesCommercial Services ORA Capital Partners Ltd. is a holding and management company whose principal activity is the development and growth of trading companies within its business portfolio. It is currently focused on technology, resources and financial services opportunities. The company operates through two segments: Business Portfolio Return & Advisory Fees and Financial Trading. The Business Portfolio Return & Advisory Fees segment represents gains and losses on the disposal and revaluation of portfolio investments held. The Financial Trading segment uses surplus cash for specific opportunities. It also engages in trading instruments and has smaller interests in a number of other companies. ORA Capital Partners was founded by Richard Ian Griffiths on November 7, 2005 and is headquartered in St. Peter Port, Guernsey. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Genomics Plc
 Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Plectrum Petroleum Plc
 Plectrum Petroleum Plc Oil & Gas ProductionEnergy Minerals Part of Baron Oil Plc, Plectrum Petroleum Plc is a British company that explores for oil and natural gas offshore. The private company is based in Banchory, UK. The company was founded by David Robert Norwood, Michael Whyatt. Plectrum Petroleum was acquired by Gold Oil Caribbean Ltd. from Capricorn Energy Plc on October 13, 2008. | Oil & Gas Production | Founder Director/Board Member | |
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Founder Director/Board Member | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
COE Group Ltd.
 COE Group Ltd. Electronics/AppliancesConsumer Durables Coe Group Ltd. designs and manufactures products for surveillance, transmission and management of video over internet protocol, fiber and hybrid video networks. The company was founded by Mark Marriage and Mark Waddington on April 20, 1913 and is headquartered in Abingdon, the United Kingdom. | Electronics/Appliances | Director of Finance/CFO Chairman | |
| The Cancer Drug Development Forum | Director/Board Member Director/Board Member | ||
| E-THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director of Finance/CFO Corporate Officer/Principal | |
| University of Glasgow | College/University | Doctorate Degree Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Manchester | College/University | Undergraduate Degree Doctorate Degree | |
IP2IPO Ltd.
 IP2IPO Ltd. Miscellaneous Commercial ServicesCommercial Services Part of IP Group Plc, IP2IPO Ltd. is a British company that provides management consultancy services. The private company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Crescendo Biologics Ltd.
 Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
IP Assist Services Ltd.
 IP Assist Services Ltd. Miscellaneous Commercial ServicesCommercial Services IP Assist Services Ltd. provides financial services. The company is headquartered in Leeds, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Salunda Ltd.
 Salunda Ltd. Electronic Equipment/InstrumentsElectronic Technology Salunda Ltd. develops market sensor technologies, equipment and fluid monitoring solutions for harsh environments. Its products can warn of imminent failure by detecting cracks, eccentric motion, orbiting, axial shift or vibration. The company was founded in 2005 and is headquartered in Bicester, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| CERES POWER HOLDINGS PLC | Electronic Production Equipment | Chairman Director/Board Member | |
| IP Industry Partners Ltd. | Director/Board Member Director/Board Member | ||
| IP2IPO Services Ltd. | Director/Board Member Director/Board Member | ||
| Techtran Investments Ltd. | Director/Board Member Director/Board Member | ||
| Techtran Services Ltd. | Director/Board Member Director/Board Member | ||
Pulmagen Therapeutics LLP
 Pulmagen Therapeutics LLP Pharmaceuticals: MajorHealth Technology Pulmagen Therapeutics Ltd. manufactures and develops respiratory drugs. Its services include pulmagen respiratory product pipeline, pulmagen crth2 antagonist product pipeline, new generation bronchodilators-astrazeneca collaboration, theocort-inhaled corticosteroid re-sensitisation, inhaled ppar gamma agonists and chiesi collaboration-anti-inflammatory agents. The company was founded in February 2010 and is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMBRX INC | Pharmaceuticals: Major | Director/Board Member Chairman | |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Chairman |
Statistik
International
| Vereinigtes Königreich | 43 |
| Vereinigte Staaten | 6 |
| Belgien | 2 |
| Cayman Islands | 2 |
Sektoral
| Health Technology | 15 |
| Commercial Services | 11 |
| Consumer Services | 7 |
| Electronic Technology | 6 |
| Finance | 4 |
Operativ
| Director/Board Member | 288 |
| Corporate Officer/Principal | 82 |
| Chairman | 66 |
| Director of Finance/CFO | 50 |
| Independent Dir/Board Member | 39 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Alan Aubrey | 52 |
| Alison Fielding | 34 |
| Michael Bretherton | 33 |
| Samuel Cameron Williams | 27 |
| Paul Maier | 25 |
| Clive Dix | 24 |
| David Robert Norwood | 22 |
| Mario Polywka | 20 |
| Piers John Morgan | 18 |
| Ian David Jefferson | 18 |
| Eva-Lotta Allan | 17 |
| Thomas Engelen | 16 |
| Gordon James Hall | 16 |
| John Samuel | 15 |
| Harry Finch | 15 |
- Börse
- Insiders
- Alexander Stevenson
- Unternehmensverbindungen
